Manmeet Soni - Feb 28, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role: COO, CFO and President
Signature: /s/ Tracy Herson, attorney-in-fact
Stock symbol: RETA
Transactions as of: Feb 28, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/1/2023, 03:16 PM
Previous filing: Jan 4, 2023
Next filing: Mar 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Employee Stock Option (right-to-buy)	Award	$0	+75K		$0.00	75K	Feb 28, 2023	Class A common stock	75K	$34.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 16, 2022, the reporting person was granted an option to purchase 75,000 shares of Class A common stock. On February 28, 2023 based on the satisfaction of certain performance criteria, the option vested as to 14,063 shares and is set to vest 1/16th of the original grant on each three month anniversary such that 100% of the options will be vested on the four-year anniversary of the date of grant, subject to continued service through each vesting date.

Content

On September 16, 2022, the reporting person was granted an option to purchase 75,000 shares of Class A common stock. On February 28, 2023 based on the satisfaction of certain performance criteria, the option vested as to 14,063 shares and is set to vest 1/16th of the original grant on each three month anniversary such that 100% of the options will be vested on the four-year anniversary of the date of grant, subject to continued service through each vesting date.